Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays 'Revision: v3.4.2' and no longer shows 'Revision: v3.4.1'.SummaryDifference0.0%

- Check19 days agoChange DetectedPlain Language Summary has been added to the Study Details page, and the record shows a new revision (v3.4.1). The previous revision (v3.4.0) was removed and new date entries for 2026-02-05, 2026-01-15, and 2025-12 were added.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded UI controls to show/hide the glossary and updated metadata sections to include Last Update Submitted that Met QC Criteria and Last Update Posted, plus No FEAR Act Data with Revision: v3.4.0. Removed the older labels and the previous revision v3.3.4.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision 3.3.4 was added and Revision 3.3.3 was removed. This change affects only the revision history and does not alter core study content or user-facing information.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded an extensive list of Locations across multiple countries and regions. This expands where patients can participate in the trial.SummaryDifference3%

- Check91 days agoChange DetectedThe Publications section text was slightly revised and the page revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.